• Mashup Score: 4
    Become a Reviewer | ASCO Publications - 13 hour(s) ago

    Participate as a journal reviewer and play an integral role in maintaining the quality and integrity of JCO Journals content, keep up-to-date on the latest research results, increase your exposure to key leaders in oncology, and advance your career. ASCO members who become reviewers can also earn FASCO points. Earn FASCO Points. Reviewers who complete at least three reviews for JCO Journals in a calendar year will receive three points towards the FASCO distinction. The FASCO distinction recognizes ASCO

    Source: ascopubs.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of KVanLoonMD
      KVanLoonMD

      If you would like to be recognized as a certified ✅ reviewer in our database, submit an application to @JCOGO_ASCO. You will then receive instructions on completing a peer review course. https://t.co/Q6tp9kwWuR

  • Mashup Score: 6
    Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy | JCO Oncology Practice - 13 hour(s) ago

    In this issue of JCO Oncology Practice, Majhail et al 1 describe their organization’s experience with outpatient chimeric antigen receptor T-cell (CAR-T) cell therapy using a remote patient monitoring (RPM) system. The continued growth of cellular immunotherapy with its unique delivery model requires treatment centers administering this type of therapy to overcome obstacles related to physical infrastructure, technical resources, insurance coverage, and patient access. Related to access, Majhail et al 1

    Source: ascopubs.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of jamecancerdoc
      jamecancerdoc

      Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy | @JCOOP_ASCO #jcoop https://t.co/8HUvpqgarE https://t.co/rCNSyqMffR

  • Mashup Score: 5
    Liquid Biopsy Approaches for Cancer Characterization, Residual Disease Detection, and Therapy Monitoring - 1 day(s) ago

    Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) and has become a powerful tool in the diagnosis and treatment of solid tumors. Current applications include comprehensive genomic profiling for identifying …#Liquidbiopsy @ASCO educational resource on circulating tumor DNA biology, technologies, current and future applications.

    Source: ascopubs.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Liquid Biopsy Approaches for Cancer Characterization, Residual Disease Detection, and Therapy Monitoring [Apr 30, 2025] @JackieAredoMD et al. @ASCO #ASCO25 Education Book https://t.co/ad8sKZHVXY #LiquidBiopsy

  • Mashup Score: 11
    Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology - 2 day(s) ago

    Artificial intelligence (AI) is transforming multidisciplinary oncology at an unprecedented pace, redefining how clinicians detect, classify, and treat cancer. From earlier and more accurate diagnoses to personalized treatment planning, AI’s impact is …Discover how AI-driven multidisciplinary care is reshaping cancer detection, treatment, and global access. A must-read for oncology innovators. #ASCO25 #AI #CancerCare

    Source: ascopubs.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of DrBonillaOnc
      DrBonillaOnc

      Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book https://t.co/TNOIaek0nf

  • Mashup Score: 11
    Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology - 2 day(s) ago

    Artificial intelligence (AI) is transforming multidisciplinary oncology at an unprecedented pace, redefining how clinicians detect, classify, and treat cancer. From earlier and more accurate diagnoses to personalized treatment planning, AI’s impact is …Discover how AI-driven multidisciplinary care is reshaping cancer detection, treatment, and global access. A must-read for oncology innovators. #ASCO25 #AI #CancerCare

    Source: ascopubs.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of DrBonillaOnc
      DrBonillaOnc

      Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book https://t.co/TNOIaek0nf

  • Mashup Score: 47
    Perioperative Therapy in Oncogene-Driven Non–Small Cell Lung Cancer: Current Strategies and Unanswered Questions - 2 day(s) ago

    Perioperative therapy has become a critical component in the management of resectable non–small cell lung cancer (NSCLC), particularly in the era of precision medicine. Although molecular testing is standard in metastatic NSCLC, its incorporation into …We summarize the latest studies in oncogene-driven NSCLC in the perioperative setting! Read now to get up to speed.

    Source: ascopubs.org
    Categories: General Medicine News
    Tweet Tweets with this article
    • Profile photo of n8pennell
      n8pennell

      Perioperative Therapy in Oncogene-Driven Non–Small Cell Lung Cancer: Current Strategies and Unanswered Questions | American Society of Clinical Oncology Educational Book https://t.co/OiPeK0Uxu1 #ASCO25 #EdBook https://t.co/NICk9LCGmz

Load More